BES, the specialist in design and construction of ‘technically complex environments’ for the pharmaceutical, healthcare, and advanced scientific sectors, has won contract for a global medical device manufacturing facility located near Glasgow.
The company will be principal designer and principal contractor on the project for Terumo Aortic, part of Terumo Corporation based in Tokyo. Terumo Aortic manufactures surgical, endovascular, and hybrid products that clinicians worldwide use to treat patients with aortic disease. BES will be responsible for process, architectural, and building services design of what it says will be ‘a unique manufacturing environment’, along with fit-out and procurement of the facility’s specialist production equipment.
It has reviewed an initial concept design, and is currently revising this with an updated scope. ‘Overcoming the challenges of COVID-19 restrictions and social distancing’, it has worked collaboratively with Terumo Aortic through online workshops, and leveraged digital technologies to progress the project. The multidisciplinary BES team will develop a number of potential concept designs prior to an optioneering process, followed by a detailed design and construction of the final solution.
BES project lead, Sean Ferguson explains: “The new production plant will enable the client to move from manual batch production to fully automated continuous flow production and digital integration, with embedded quality control, accurate consistency, and traceability, for every device manufactured.”
The project will bring together production and packaging of Terumo Aortic’s portfolio in a single 2,400 m2 manufacturing facility. BES’s design brief includes classified cleanrooms, plant rooms, and supporting ancillary accommodation over two floors, walk-on maintenance decks, full mechanical and electrical services, and bespoke process equipment.
Erik Pomp, Terumo Aortic’s COO, added: “We require a visionary, state-of-the-art, world- class medical device facility to achieve operational excellence in quality, production, and supply. BES’s technical expertise and solutions-driven approach, combined with its track record in the pharmaceutical sector, mean it has both the skills and creativity to deliver a complete solution.”
